PF-04479745 is a research ligand developed by Pfizer. It is related to lorcaserin, and acts as a potent and selective agonist for the 5-HT<sub>2C</sub> receptor, with lower affinity and antagonist action at the related 5-HT<sub>2A</sub> and 5-HT<sub>2B</sub> receptor subtypes.